Coronavirus disease 2019 (COVID-19) is a highly heterogeneous disease regarding
severity, vulnerability to infection due to comorbidities, and treatment approaches. The …

The COVID-19 pandemic has raised considerable concerns that patients with inflammatory
bowel disease (IBD), particularly those treated with immunosuppressive therapies, may …

Thyroid and pituitary disorders linked to the coronavirus SARS-CoV-2, responsible for the
COVID-19 epidemic, are mainly due to direct infection of the endocrine glands by the virus …

Coronavirus disease 2019 (COVID-19) is well known for its respiratory complications;
however, it can also cause extrapulmonary manifestations, including cardiovascular …

Background Patients hospitalised with severe acute respiratory syndrome coronavirus 2
[SARS-CoV-2; coronavirus 2019 disease (COVID-19)] infection are frequently older with co …

SARS-CoV-2 infection or COVID-19 has become a worldwide pandemic; however, effective
treatment for COVID-19 remains to be established. Along with acute respiratory distress …

Abstract Purpose: Coronavirus disease–2019 (COVID-19) continues to be a global threat
and remains a significant cause of hospitalizations. Recent clinical guidelines have …

Many current treatment options for lung inflammation and thrombosis come with unwanted
side effects. The natural omega-3 fatty acids (O3FA) are generally anti-inflammatory and …

Abstract Purpose Coronavirus disease-19 (COVID-19) has spread throughout the world. It
was initially defined as a potentially severe syndrome affecting the respiratory tract, but it has …

The novel coronavirus disease 2019 (COVID-19) is a global pandemic that continues to
sweep across the world, posing an urgent need for effective therapies and prevention of the …